Genetic Technologies Limited (GENE) - News Archive

In a significant move that underscores its commitment to advancing genomics in healthcare, Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has announced its partnership with CancerIQ, an online platform that boast...

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE), a preeminent name in the field of genomics-based health tests, has unveiled a groundbreaking advancement with the global launch of its geneType Risk Assessment port...

CHARLOTTE, N.C., July 26, 2024: Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GENE), a global leader in genomics-based testing for health, wellness, and serious diseases, has announced a significant str...

In recent weeks, Genetic Technologies Limited (GTG), a global leader in genomics-based tests in health and wellness, has been experiencing a decline in performance compared to the overall market. This article aims to an...

Genetic Technologies Limited (GTG), an Australia-based genomics test provider, has officially inked a business-to-business (B2B) sales and marketing agreement with Pennsylvania s wellness program management provider, We...

GTG Unveils Ambitious Digital Media Sales Campaign to Tap into Growing U.S. Wellness Testing MarketGenetic Technologies Limited (GTG), a leading provider of genetic risk assessment tests, has recently announced its plan...

Genetic Technologies Limited (NASDAQ: GENE) is making significant strides in the field of personalized predictive genomics, transforming the healthcare industry with its groundbreaking approach to early disease detectio...

Melbourne, Australia - In an exciting development, Genetic Technologies Limited (NASDAQ: GENE) announces that it has regained compliance with the minimum bid price requirement prescribed by the Nasdaq Stock Market, LLC...